TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7923516

Group type: EXPERIMENTAL
Intervention: Atracurium 0.5 mg.kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Atracurium 0.75 mg.kg‐1
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Atracurium 1 mg.kg‐1
Number of subjects: 80

Group type: COMPARATOR
Intervention: Succinylcholine 1.5 mg.kg‐1 (Control)
Number of subjects: 80
Study: 3407900

Group type: EXPERIMENTAL
Intervention: Oral intubation with a laryngoscope (Group A, n = 50)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Nasal intubation using a fiberoptic endoscope (Group B, n = 40)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Face mask (Group C, n = 50)
Number of subjects: 140
Study: 29514121

Group type: EXPERIMENTAL
Intervention: Maladaptive interpersonal beliefs measured by the Interpersonal Needs Questionnaire (INQ)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Facial emotion recognition accuracy (Penn ER‐40)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Bias toward perceiving anger in neutral expressions
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cognitive ability adjustment
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Schizophrenia vs. bipolar disorder
Number of subjects: 101
Study: 28579406

Group type: EXPERIMENTAL
Intervention: Freeze-all policy
Number of subjects: 171
Study: 26331956

Group type: EXPERIMENTAL
Intervention: High-fat meal rich in polyunsaturated fatty acids (PUFAs)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-fat meal rich in monounsaturated fatty acids (MUFAs)
Number of subjects: 16

Group type: COMPARATOR
Intervention: High-fat meal rich in saturated fatty acids (SFAs)
Number of subjects: 16
Study: 23964826

Group type: EXPERIMENTAL
Intervention: Modified Glamorgan Scale (mGS)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Glamorgan Scale (GS)
Number of subjects: 112
Study: 20100734

Group type: EXPERIMENTAL
Intervention: Intra-dialytic low-intensity strength training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Stretching (attention-control) exercises
Number of subjects: 50
Study: 18251642

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy delivered for 20 minutes using a piezoelectric transducer for 10 sessions over 4 weeks.
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no ultrasound therapy)
Number of subjects: 12
Study: 17034311

Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg via Turbuhaler
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Salbutamol 200 microg (metered dose inhaler)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Formoterol 6 microg via Turbuhaler
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 176
Study: 14605789

Group type: EXPERIMENTAL
Intervention: Microcrystalline chitosan (MCC) 1.2 g twice daily
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo 1.2 g twice daily
Number of subjects: 130
Study: 11128753

Group type: EXPERIMENTAL
Intervention: Bilateral reduction mammaplasty
Number of subjects: 69

Group type: COMPARATOR
Intervention: Preoperative state
Number of subjects: 69

Group type: COMPARATOR
Intervention: Nonpatient control groups
Number of subjects: 69
Study: 9232667

Group type: EXPERIMENTAL
Intervention: Guaiphenesin and bromhexine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (30 mg single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1596352

Group type: EXPERIMENTAL
Intervention: Low-air loss bed (Mediscus)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Foam mattress with loose-fitting top cover (Comfortex)
Number of subjects: 20
Study: 2982694

Group type: EXPERIMENTAL
Intervention: Vegetable protein diet supplemented with psyllium fiber (0.8 g/kg body wt, 1800 kcal/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Meat protein diet (0.8 g/kg body wt, approximately 1800 kcal/day) plus neomycin and laxatives
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vegetable protein diet plus fiber
Number of subjects: 8
Study: 31093740

Group type: EXPERIMENTAL
Intervention: Betamethasone
Number of subjects: 2324
Study: 27613912

Group type: EXPERIMENTAL
Intervention: Combined nicotine replacement therapy (NRT) and behavioral counseling
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group (non-abstainers)
Number of subjects: 269
Study: 26845524

Group type: EXPERIMENTAL
Intervention: 10-Hz rTMS
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Anodal 2-mA tDCS
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 35
Study: 25033113

Group type: EXPERIMENTAL
Intervention: Group-based cognitive processing therapy (CPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual support
Number of subjects: 0
Study: 22399366

Group type: EXPERIMENTAL
Intervention: Transient ischemic dilation (TID)
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: TID combined with mild to moderate perfusion abnormality (3% ≤ TPD < 10%)
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: TID(ed)/TID(es)
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Duke prognostic CAD index (DI)
Number of subjects: 547
Study: 19155521

Group type: EXPERIMENTAL
Intervention: HPV-16 L1 VLP vaccine
Number of subjects: 21
Study: 17969818

Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment (short‐acting insulin in each meal and medium‐acting insulin before going to bed)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional insulin treatment (two doses: morning and evening)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment
Number of subjects: 42
Study: 15558090

Group type: EXPERIMENTAL
Intervention: Insight 'F' speed film (right side)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ultra‐Speed 'D' film (left side)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Insight Film (control, both sides)
Number of subjects: 12
Study: 11402107

Group type: EXPERIMENTAL
Intervention: Interferon-beta-1a 44 microg
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Interferon-beta-1a 22 microg
Number of subjects: 618

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 618
Study: 9402173

Group type: EXPERIMENTAL
Intervention: PVI 5‐FU + MMC
Number of subjects: 200

Group type: COMPARATOR
Intervention: PVI 5‐FU alone
Number of subjects: 200
Study: 8272992

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% (8 ml) infiltrated 5 min before incision
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Piritramide (on-demand analgesia for 24 h)
Number of subjects: 50
Study: 2888424

Group type: EXPERIMENTAL
Intervention: Cetirizine 2 HCl 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terfenadine 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Terfenadine 180 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30578215

Group type: EXPERIMENTAL
Intervention: 12-week PA telecoaching intervention using a step counter and smartphone app
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Step counter usage
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Smartphone interface usage
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Contact time groups (high, medium, low)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Overall actual usage of intervention components
Number of subjects: 159
Study: 27899130

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment (cephalexin)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 124
Study: 24424708

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation for 16 weeks
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Multivitamin supplementation
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 22518383

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (CSE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: AdhesE (ADE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Adper SE Plus (ADP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bleaching
Number of subjects: 36

Group type: COMPARATOR
Intervention: CPP‐ACP
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bleaching and CPP‐ACP
Number of subjects: 36
Study: 20845288

Group type: EXPERIMENTAL
Intervention: Intramuscular tramadol 100 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin 40 µg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin 40 µg plus intramuscular tramadol 100 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pethidine (control)
Number of subjects: 90
Study: 19027564

Group type: EXPERIMENTAL
Intervention: Microincision cataract surgery (MICS)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Small-incision cataract surgery (SICS)
Number of subjects: 74
Study: 15885513

Group type: EXPERIMENTAL
Intervention: Computerized cognitive remediation (Cogpack) for 15 sessions over 3 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 42
Study: 12648180

Group type: EXPERIMENTAL
Intervention: 150 micro g Nestorone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 200 micro g Nestorone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 400 micro g Nestorone
Number of subjects: 21
Study: 11063500

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg twice a day from the day before to 3 days after mastectomy
Number of subjects: 54
Study: 8931784

Group type: EXPERIMENTAL
Intervention: Thalidomide (100 mg by mouth, four times daily) for 12 weeks
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 28
Study: 1298087

Group type: EXPERIMENTAL
Intervention: Artemether
Number of subjects: 26

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study: 6240749

Group type: EXPERIMENTAL
Intervention: 80 micrograms of SCH 1000
Number of subjects: 10

Group type: COMPARATOR
Intervention: 800 micrograms of fenoterol
Number of subjects: 10
Study: 30852478

Group type: EXPERIMENTAL
Intervention: Fingolimod combined with alteplase
Number of subjects: 90

Group type: COMPARATOR
Intervention: Alteplase intravenous thrombolysis
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fingolimod (0.5 mg)
Number of subjects: 90
Study: 29378038

Group type: EXPERIMENTAL
Intervention: 30 g cashew nuts/day for 12 weeks
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard diabetic diet (control)
Number of subjects: 300
Study: 27772661

Group type: EXPERIMENTAL
Intervention: Asthma-related anxiety
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 349
Study: 24709926

Group type: EXPERIMENTAL
Intervention: SSTP + ACT
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: SSTP
Number of subjects: 67
Study: 22668876

Group type: EXPERIMENTAL
Intervention: PEG‐IFN α‐2a (180 μg weekly) ± ribavirin (1000‐1200 mg daily) for 48 weeks
Number of subjects: 79
Study: 20485304

Group type: EXPERIMENTAL
Intervention: Fermented dairy drink containing Lactobacillus casei DN-114 001
Number of subjects: 638

Group type: COMPARATOR
Intervention: Placebo with no live cultures
Number of subjects: 638
Study: 17506733

Group type: EXPERIMENTAL
Intervention: Midazolam-propofol group (midazolam at 0.1 mg.kg(‐1) followed by propofol at 1.5 mg.kg(‐1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Propofol group (propofol at 2.5 mg.kg(‐1))
Number of subjects: 40
Study: 16163516

Group type: EXPERIMENTAL
Intervention: MDMA (2 mg/kg, p.o.)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 12149701

Group type: EXPERIMENTAL
Intervention: Portal decompression procedure
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Liver transplantation (LTx)
Number of subjects: 43
Study: 10591433

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (20-40 microg)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin
Number of subjects: 399
Study: 8785234

Group type: EXPERIMENTAL
Intervention: Swan neck catheter
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tenckhoff catheter
Number of subjects: 40
Study: 2261147

Group type: EXPERIMENTAL
Intervention: Quinapril (10 to 40 mg/day)
Number of subjects: 225

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 225
Study: 6360297

Group type: EXPERIMENTAL
Intervention: Colposuspension
Number of subjects: 51

Group type: COMPARATOR
Intervention: Stamey-type bladder neck suspension
Number of subjects: 51
Study: 30409409

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate infusion (500mg.day‐1 for 21 days)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Milrinone infusion (0.5μg.kg‐1.min‐1 for 21 days)
Number of subjects: 90
Study: 29509598

Group type: EXPERIMENTAL
Intervention: Vaginal estradiol in softgel capsules
Number of subjects: 2

Group type: COMPARATOR
Intervention: Vaginal pH assessment
Number of subjects: 2
Study: 26857563

Group type: EXPERIMENTAL
Intervention: Electronic booster feedback (n=175)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Assessment only (n=171)
Number of subjects: 346
Study: 25095322

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 microg/kg (D1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1.5 microg/kg (D2)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Midazolam 0.2 mg/kg (M1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Ketamine 5 mg/kg (K1)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D1, D2)
Number of subjects: 84
Study: 22257365

Group type: EXPERIMENTAL
Intervention: SRA+G (Standard Risk Assessment with Genetic Testing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SRA (Standard Risk Assessment without Genetic Testing)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-test arm (Standard Risk Assessment without Genetic Testing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All arms (SRA+G, SRA, No-test)
Number of subjects: 0
Study: 19074488

Group type: EXPERIMENTAL
Intervention: Chinese version of the SNAP-IV-Teacher Form
Number of subjects: 3843
Study: 17165061

Group type: EXPERIMENTAL
Intervention: Warm up (light running followed by stretching and two ballet exercises)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No warm up
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Warm up
Number of subjects: 12
Study: 16829763

Group type: EXPERIMENTAL
Intervention: 1.11 GBq (30 mCi) (131)I with the aid of rhTSH
Number of subjects: 93

Group type: COMPARATOR
Intervention: 1.11 GBq (30 mCi) (131)I in hypothyroid state
Number of subjects: 93
Study: 14520944

Group type: EXPERIMENTAL
Intervention: Amoxicillin (1 g/day) and clarithromycin (0.5 g/day) for 10 days along with omeprazole (40 mg/day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Omeprazole (40 mg/day) only
Number of subjects: 66
Study: 11153413

Group type: EXPERIMENTAL
Intervention: Intensified communication (4 phone calls to GP, RF booklet provided)
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1042
Study: 8799523

Group type: EXPERIMENTAL
Intervention: bretazenil (0.5 mg) + alcohol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: diazepam (10 mg) + alcohol
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: bretazenil (0.5 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: diazepam (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: alcohol
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 1622853

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus ifosfamide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Epidoxorubicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doxorubicin alone or with other polychemotherapeutic regimens without ifosfamide
Number of subjects: 0
Study: 6723769

Group type: EXPERIMENTAL
Intervention: 200 mg cimetidine with 11 g aluminium phosphate
Number of subjects: 22

Group type: COMPARATOR
Intervention: 200 mg cimetidine with water
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Prednisolone with 11 g aluminium phosphate
Number of subjects: 22

Group type: COMPARATOR
Intervention: Prednisolone alone
Number of subjects: 22
Study: 29939885

Group type: EXPERIMENTAL
Intervention: Polyhexamethylene biguanide (PHMB) solution
Number of subjects: 44

Group type: COMPARATOR
Intervention: 0.9% saline solution
Number of subjects: 44
Study: 28473423

Group type: EXPERIMENTAL
Intervention: Abatacept 125 mg subcutaneously weekly for 24 weeks
Number of subjects: 424

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 424
Study: 26181196

Group type: EXPERIMENTAL
Intervention: Kinesiology tape (SpiderTech kinesiology tape precut Shoulder Spider) applied to the shoulder
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no kinesiology tape)
Number of subjects: 16
Study: 23131717

Group type: EXPERIMENTAL
Intervention: 2.0 mg ranibizumab injections monthly for 3 doses
Number of subjects: 87
Study: 21441163

Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 8290

Group type: COMPARATOR
Intervention: Contrast ventriculography (CNV)
Number of subjects: 8290

Group type: COMPARATOR
Intervention: Radionuclide angiography (RNA)
Number of subjects: 8290
Study: 17972070

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Oxcarbazepine (OXCBZ)
Number of subjects: 60
Study: 15947626

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) 200 U
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) 300 U
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 12700373

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (high dose, 3.1 microg per square millimeter)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (low dose, 1.3 microg per square millimeter)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control stent
Number of subjects: 177
Study: 10839292

Group type: EXPERIMENTAL
Intervention: Chemotherapy (fluoropyrimidine-based, various routes and schedules)
Number of subjects: 614

Group type: COMPARATOR
Intervention: No chemotherapy (observation or supportive care)
Number of subjects: 614
Study: 8640053

Group type: EXPERIMENTAL
Intervention: Maternal smoking during pregnancy
Number of subjects: 933
Study: 1642184

Group type: EXPERIMENTAL
Intervention: Atrial overdrive pacing with extrastimuli
Number of subjects: 22

Group type: COMPARATOR
Intervention: Short burst atrial overdrive pacing
Number of subjects: 22

Group type: COMPARATOR
Intervention: Long burst atrial overdrive pacing
Number of subjects: 22
Study: 6729582

Group type: EXPERIMENTAL
Intervention: Harrington instrumentation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Harrington rods
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Early surgical intervention
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Open reduction and stabilization with Harrington rods and fusion within three days after injury
Number of subjects: 14
Study: 31094482

Group type: EXPERIMENTAL
Intervention: Mertenil® at initial dosage of 10 mg/day (Scheme I)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Ekvamer® 5/10/10 mg/day (Scheme II)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Mertenil® 10 mg/day + Ekvator® 5/10 mg/day (Scheme III)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Fenofibrate intake in a dose of 145 mg/day (for TG >2.3 mmol/l)
Number of subjects: 702

Group type: EXPERIMENTAL
Intervention: Compliant patients (n = 590)
Number of subjects: 702

Group type: COMPARATOR
Intervention: Non-compliant patients
Number of subjects: 702
Study: 27499527

Group type: EXPERIMENTAL
Intervention: Systematic oral care by the researcher
Number of subjects: 100

Group type: COMPARATOR
Intervention: Oral care by nurses (Control)
Number of subjects: 100
Study: 25567558

Group type: EXPERIMENTAL
Intervention: Staples
Number of subjects: 350

Group type: COMPARATOR
Intervention: Suture
Number of subjects: 350
Study: 24810310

Group type: EXPERIMENTAL
Intervention: HMB, arginine and glutamine mixture alongside oral nutritional supplements (n=11)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Standard nutritional care alongside oral nutritional supplements (n=12)
Number of subjects: 23
Study: 22950805

Group type: EXPERIMENTAL
Intervention: CVAR assessment by GPs
Number of subjects: 15
Study: 20024738

Group type: EXPERIMENTAL
Intervention: Health education intervention aimed at enhancing coping skills and consistent condom use
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Health education intervention
Number of subjects: 120
Study: 17334592

Group type: EXPERIMENTAL
Intervention: LHRH agonist (leuprolide acetate 7.5 mg/month)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Antiandrogen monotherapy (bicalutamide 50 mg q.d., nilutamide 150 mg t.i.d., flutamide 250 mg t.i.d.)
Number of subjects: 97
Study: 15527426

Group type: EXPERIMENTAL
Intervention: Bright light treatment (white light, 10,000 lux, 1 h daily)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo treatment (red light, 50 lux, 30 min daily)
Number of subjects: 102
Study: 11049974

Group type: EXPERIMENTAL
Intervention: Pentostatin
Number of subjects: 241
Study: 9277070

Group type: EXPERIMENTAL
Intervention: Amphotericin B (0.3 mg/kg/d) + Flucytosine (150 mg/kg/d) + Itraconazole (400 mg/d)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Amphotericin B + Flucytosine
Number of subjects: 100
Study: 8417242

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 3766376

Group type: EXPERIMENTAL
Intervention: Pindolol and Verapamil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31090337

Group type: EXPERIMENTAL
Intervention: Modified Buyang Huanwu Decoction (in addition to rt-PA intravenous thrombolysis)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Control group (rt-PA intravenous thrombolysis only)
Number of subjects: 212
Study: 29024233

Group type: EXPERIMENTAL
Intervention: 75 mg of low-dose aspirin (LDA) plus 4100 U of low molecular weight heparin (LMWH) subcutaneously daily
Number of subjects: 1015

Group type: COMPARATOR
Intervention: 75 mg of low-dose aspirin (LDA) alone
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Normal D-dimer levels at all blood draw points
Number of subjects: 1015

Group type: EXPERIMENTAL
Intervention: Persistently abnormal D-dimer or increased D-dimer after treatment
Number of subjects: 1015